<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0299-4908-00
</NDCCode>
<PackageDescription>
2 g in 1 TUBE (0299-4908-00)
</PackageDescription>
<NDC11Code>
00299-4908-00
</NDC11Code>
<ProductNDC>
0299-4908
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Differin Epiduo
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Adapalene And Benzoyl Peroxide
</NonProprietaryName>
<DosageFormName>
GEL
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20260522
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA220736
</ApplicationNumber>
<LabelerName>
Galderma Laboratories, L.P.
</LabelerName>
<SubstanceName>
ADAPALENE; BENZOYL PEROXIDE
</SubstanceName>
<StrengthNumber>
1; 25
</StrengthNumber>
<StrengthUnit>
mg/g; mg/g
</StrengthUnit>
<Pharm_Classes>
Retinoid [EPC], Retinoids [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-05-25
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260522
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
Y
</SamplePackage>
</NDC>